Medicare Enrolled
Dr. David Valentine, M.D.
Neurology · South Pasadena, CA
Practice pattern: Remote Monitoring
— Significant remote device monitoring activity
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Valentine from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Valentine?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Valentine
Dr. David Valentine is a neurology specialist in South Pasadena, CA, with 10 years of NPI registration. Based on federal Medicare data, Dr. Valentine performed 3,096 Medicare services across 2,685 unique beneficiaries.
Between the years covered by Open Payments, Dr. Valentine received a total of $5,762 from 45 pharmaceutical and/or device companies across 291 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Valentine is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 10 years in practice
▲ Top 18% volume in CA
$5,762 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,096
Medicare services
Top 18% in CA for neurology
2,685
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~310 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Placement of skin electrodes and measurement of stimulated sites on arms and legs This procedure involves placing skin electrodes and measuring stimulated sites on the arms and legs. |
484 | $34 | $5,614 |
| Intraoperative EEG monitoring Recording brain wave activity during surgery to monitor neurological function. |
446 | $41 | $2,923 |
| Electromyography of 2 extremities A test that measures the electrical activity in the muscles of two arms or legs. It helps evaluate nerve and muscle function. |
419 | $62 | $2,395 |
| Nerve-muscle junction testing A diagnostic test used to evaluate the function of the connection between nerves and muscles. |
390 | $26 | $1,619 |
| Central motor stimulation test of arms and legs This procedure involves placing skin electrodes on the body to measure how the central nervous system stimulates the muscles in the arms and legs. |
216 | $91 | $8,551 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
207 | $106 | $165 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
127 | $86 | $175 |
| Continuous intraoperative neurophysiology monitoring, remote Remote monitoring of nerve and brain function during surgery, billed in 15-minute increments. |
111 | $25 | $428 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
91 | $414 | $560 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
62 | $151 | $215 |
| New patient office visit, complex (60-74 min) | 59 | $186 | $275 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
56 | $248 | $550 |
| Video EEG monitoring, 2-12 hours This procedure records brain wave activity while simultaneously capturing video footage for a duration of 2 to 12 hours. A healthcare professional reviews the data and provides a report. |
54 | $114 | $378 |
| Needle electromyography of trunk or head muscles A test that uses a needle electrode to measure the electrical activity of muscles in the trunk or head. This helps evaluate muscle and nerve function. |
49 | $73 | $200 |
| VEEG monitoring, 12-26 hours with review This procedure involves monitoring brain wave activity along with video recording for 12 to 26 hours. A healthcare professional reviews the data and provides a report. |
43 | $175 | $584 |
| Nerve conduction study, 1-2 tests A test that measures how well nerves send electrical signals to evaluate nerve function. |
39 | $40 | $1,321 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
34 | $140 | $250 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
30 | $13 | $40 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
30 | $1 | $17 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
29 | $124 | $300 |
| Placement of skin electrodes and measurement of stimulated sites in arms Skin electrodes are placed on the arms to measure the response to stimulation at specific sites. |
26 | $23 | $2,808 |
| Limited needle electromyography A test that measures the electrical activity in muscles of the arm, leg, trunk, or head using a needle electrode. This limited study evaluates muscle function and nerve health. |
21 | $15 | $1,303 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
20 | $46 | $200 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 20 | $90 | $200 |
| Central motor stimulation measurement with skin electrodes Skin electrodes are placed to measure central motor stimulation in the arms. |
19 | $66 | $3,631 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
14 | $100 | $165 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,762
Total received (2021-2024)
Avg $1,441/year across 4 years
Top 31% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
291
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,750 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,102
2023
$1,437
2022
$745
2021
$478
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$696
ABBVIE INC.
$527
Lilly USA, LLC
$246
Alexion Pharmaceuticals, Inc.
$175
JAZZ PHARMACEUTICALS INC.
$172
Corium, LLC
$149
Neurelis, Inc.
$126
PFIZER INC.
$119
Avadel CNS Pharmaceuticals, LLC
$104
Celgene Corporation
$96
Grifols USA, LLC
$94
Biogen, Inc.
$49
Alnylam Pharmaceuticals Inc.
$46
Harmony Biosciences Llc
$45
HARMONY BIOSCIENCES LLC
$45
Teva Pharmaceuticals USA, Inc.
$40
AstraZeneca Pharmaceuticals LP
$34
Sarepta Therapeutics, Inc.
$33
Takeda Pharmaceuticals U.S.A., Inc.
$33
SK Life Science, Inc.
$30
MITSUBISHI TANABE PHARMA AMERICA, INC.
$30
Amneal Pharmaceuticals LLC
$28
ACADIA Pharmaceuticals Inc
$26
AQUESTIVE THERAPEUTICS, INC.
$25
Eisai Inc.
$22
Kyowa Kirin, Inc.
$22
Sumitomo Pharma America, Inc.
$19
SCILEX PHARMACEUTICALS INC.
$19
Xeris Pharmaceuticals, Inc.
$18
Ultragenyx Pharmaceutical Inc.
$17
CATALYST PHARMACEUTICALS, INC.
$17
Top 3 companies account for 47.4% of 2024 payments
All-time payments by company (2021-2024) ›
UCB, Inc.
$1,109
ABBVIE INC.
$747
Lilly USA, LLC
$413
JAZZ PHARMACEUTICALS INC.
$368
AbbVie Inc.
$322
Alexion Pharmaceuticals, Inc.
$293
Corium, LLC
$191
PFIZER INC.
$180
Teva Pharmaceuticals USA, Inc.
$170
Neurelis, Inc.
$146
Alnylam Pharmaceuticals Inc.
$134
Avadel CNS Pharmaceuticals, LLC
$126
Allergan, Inc.
$124
Sumitomo Pharma America, Inc.
$117
LivaNova USA, Inc.
$110
Celgene Corporation
$96
Grifols USA, LLC
$94
Biogen, Inc.
$90
CSL Behring
$69
AQUESTIVE THERAPEUTICS, INC.
$61
Greenwich Biosciences, Inc.
$57
Takeda Pharmaceuticals U.S.A., Inc.
$56
IDORSIA PHARMACEUTICALS US INC
$52
Amneal Pharmaceuticals LLC
$52
ACADIA Pharmaceuticals Inc
$50
Harmony Biosciences Llc
$45
HARMONY BIOSCIENCES LLC
$45
ARGENX US, INC.
$41
AstraZeneca Pharmaceuticals LP
$34
Sarepta Therapeutics, Inc.
$33
Xeris Pharmaceuticals, Inc.
$32
Biohaven Pharmaceutical Holding Company Ltd.
$30
SK Life Science, Inc.
$30
MITSUBISHI TANABE PHARMA AMERICA, INC.
$30
Biohaven Pharmaceuticals, Inc.
$28
Axsome Therapeutics, Inc.
$27
Eisai Inc.
$22
Kyowa Kirin, Inc.
$22
MDD US Operations, LLC
$21
SCILEX PHARMACEUTICALS INC.
$19
Ultragenyx Pharmaceutical Inc.
$17
Scilex Pharmaceuticals Inc.
$17
CATALYST PHARMACEUTICALS, INC.
$17
Azurity Pharmaceuticals, Inc.
$13
IMPEL PHARMACEUTICALS INC.
$12
Top 3 companies account for 39.4% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AGAMREE · AJOVY · AMVUTTRA · AMYVID · APTIOM · AUSTEDO · Austedo XR · Azstarys · BOTOX · Briviact · DAYBUE · EMGALITY · Elevidys · Epidiolex · Fintepla · Gamunex-C · HYQVIA · Hizentra · Horizant · KEVEYIS · KISUNLA · LIBERVANT · LUMRYZ · Leqembi · NURTEC ODT · Nayzilam · Nourianz · ONPATTRO · QALSODY · QULIPTA · QUVIVIQ · RADICAVA · RYTARY · Rystiggo · SOLIRIS · SPINRAZA · SYMPAZAN · Sunosi · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYVGART · WAINUA · WAKIX · XADAGO · XYWAV · ZEPOSIA · ZTLido · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
573
Per 100K population
5.8
County median income
$87,760
Nearest hospital
ALHAMBRA HOSPITAL MEDICAL CENTER
2.1 mi
2.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Valentine is a remote monitoring specialist, with above-average Medicare volume (top 18% in CA), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Valentine experienced with placement of skin electrodes and measurement of stimulated sites on arms and legs?
Based on Medicare claims data, Dr. Valentine performed 484 placement of skin electrodes and measurement of stimulated sites on arms and legs services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Valentine receive payments from pharmaceutical companies?
Yes. Dr. Valentine received a total of $5,762 from 45 companies across 291 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Valentine's costs compare to other neurologists in South Pasadena?
Dr. Valentine's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Valentine) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in South Pasadena
Browse neurologists in South Pasadena ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology